Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Patricia M Fortin"'
Autor:
Kirstin L Wilkinson, Sally Hopewell, Simon J. Stanworth, Jonathan Huber, Susan J Brunskill, Marialena Trivella, Lise J Estcourt, Carolyn Doree, Patricia M Fortin
Publikováno v:
The Cochrane database of systematic reviews. 11
Background: In the absence of bleeding, plasma is commonly transfused to people prophylactically to prevent bleeding. In this context, it is transfused before operative or invasive procedures (such as liver biopsy or chest drainage tube insertion) in
Autor:
Marialena Trivella, Sheila A Fisher, C Doree, Karen V Madgwick, Patricia M Fortin, Lise J Estcourt, Sally Hopewell
Publikováno v:
Europe PubMed Central
The Cochrane Library
The Cochrane Library
Regularly transfused people with sickle cell disease (SCD) and people with thalassaemia (who are transfusion-dependent or non-transfusion-dependent) are at risk of iron overload. Iron overload can lead to iron toxicity in vulnerable organs such as th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262598a3110714c1688f2f9cfbfe4b45
https://doi.org/10.1002/14651858.cd012349.pub2
https://doi.org/10.1002/14651858.cd012349.pub2
Autor:
Noémi B. A. Roy, Lise J Estcourt, Patricia M Fortin, Carolyn Doree, Katherine R. Bull, Marialena Trivella, Sally Hopewell
Publikováno v:
The Cochrane Library
Background Sickle cell disease (SCD) is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta-globin) genes. SCD can cause severe pain, significant end-organ damage, pulmonary complicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f20b02405d78b30d374071ba7a2489
https://doi.org/10.1002/14651858.cd012380.pub2
https://doi.org/10.1002/14651858.cd012380.pub2
Autor:
Miguel R. Abboud, Marialena Trivella, Carolyn Doree, Lise J Estcourt, Sally Hopewell, Patricia M Fortin
Publikováno v:
The Cochrane Library
Cochrane Database Syst Rev
Cochrane Database Syst Rev
BACKGROUND: Sickle cell disease (SCD) is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta globin) genes. SCD can cause severe pain, significant end-organ damage, pulmonary complica
Publikováno v:
The Cochrane Library
Background Hypertension is a chronic condition associated with an increased risk of mortality and morbidity. Renin is the enzyme responsible for converting angiotensinogen to angiotensin I, which is then converted to angiotensin II. Renin inhibitors
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta globin) genes. Sickle cell disease can cause severe pain, significant end-organ damage, pulmonary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67d46be8aaa3b34326b53bb8e8a9a82
https://doi.org/10.1002/14651858.cd003146.pub3
https://doi.org/10.1002/14651858.cd003146.pub3
Publikováno v:
The Cochrane Library
Background: Globally, sickle cell disease (SCD) is one of the commonest severe monogenic disorders, due to the inheritance of two abnormal haemoglobin (beta globin) genes. SCD can cause severe pain, significant end‐organ damage, pulmonary complicat
Publikováno v:
Journal of Human Hypertension. 23:495-502
We conducted a systematic review and meta-analysis of double-blind randomized controlled trials to quantify the dose-related systolic (SBP) and diastolic blood pressure (DBP) lowering efficacy of renin inhibitors vs placebo in the treatment of adults
Autor:
Ian Hambleton, Sally Hopewell, Gavin Cho, Marialena Trivella, Patricia M Fortin, Lise J Estcourt
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
BACKGROUND: Sickle cell disease is a genetic haemoglobin disorder, which can cause severe pain, significant end-organ damage, pulmonary complications, and premature death. Sickle cell disease is one of the most common severe monogenic disorders in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686fdafa8810bbe290e0a957996b0692
https://doi.org/10.1002/14651858.cd008360.pub2
https://doi.org/10.1002/14651858.cd008360.pub2
Publikováno v:
Scopus-Elsevier
The Cochrane Library
The Cochrane Library
Background Intradialytic hypotension (IDH) occurs in 20% to 55% of haemodialysis sessions and is more frequent among patients on long-term haemodialysis. Symptomatic IDH is generally defined as a decrease in systolic blood pressure (BP) of at least 1